Senior insider sale
Chief Technical Ops Officer at PTC THERAPEUTICS, INC. — senior position signals high conviction
$9.18M
107.40K shares
ALMSTEAD NEIL GREGORY plans to sell 107.40K shares of PTC THERAPEUTICS, INC. valued at approximately $9.18M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Stock Option Exercise
Cash
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/9/2026 | Stock Option Exercise Cash | 2.46K | — |
| Total | 2.46K | ||
Completed
Units to sell
24.61K
Market value
$2.19M
Units to sell
22.16K
Market value
$1.91M
Units to sell
8.13K
Market value
$693.1K
Units to sell
20.96K
Market value
$1.80M
Units to sell
5.32K
Market value
$452.6K
Units to sell
23.75K
Market value
$1.92M
Planned — Approximate Date
Units to sell
2.46K
Market value
$222.4K
Units
107.40K
Value
$9.18M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/7/2026 | 24.61K | $2.19M | — | Completed |
7/6/2026 | 22.16K | $1.91M | — | Completed |
6/26/2026 | 8.13K | $693.1K | — | Completed |
6/25/2026 | 20.96K | $1.80M | — | Completed |
6/24/2026 | 5.32K | $452.6K | — | Completed |
6/22/2026 | 23.75K | $1.92M | — | Completed |
| Planned — Approximate Date | ||||
7/9/2026 | 2.46K | $222.4K | NASDAQ | Planned |
| Total | 107.40K | $9.18M | ||